The escalating conflict between the United States and Iran has raised concerns about a potential shortage of essential medicines in Nigeria, as the country relies heavily on imported drugs and active pharmaceutical ingredients (APIs) from China and India. Stakeholders in Nigeria’s pharmaceutical sector warn that disruptions to global supply chains, surging oil prices, and foreign exchange pressures may drive up the cost of medicines and medical consumables nationwide.

Nigeria imports 70% of its essential medicines, leaving local production at roughly 30% for a population of over 230 million people. The conflict has led to increased shipping costs, insurance, and logistics costs, which may cascade through the supply chain, ultimately affecting retail prices.
Experts urge the Federal Government to adopt proactive strategies, including expanding domestic drug manufacturing capacity, to reduce dependence on global supply chains. The Africa Centres for Disease Control and Prevention should be empowered to coordinate continent-wide emergency health responses.
Source: Punch news







Leave a Reply